loading
Schlusskurs vom Vortag:
$3.35
Offen:
$3.34
24-Stunden-Volumen:
1.11M
Relative Volume:
0.64
Marktkapitalisierung:
$160.82M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-44.80M
KGV:
-4.6933
EPS:
-0.75
Netto-Cashflow:
$-30.67M
1W Leistung:
+10.88%
1M Leistung:
+58.33%
6M Leistung:
-26.08%
1J Leistung:
+5.56%
1-Tages-Spanne:
Value
$3.29
$3.64
1-Wochen-Bereich:
Value
$2.95
$3.64
52-Wochen-Spanne:
Value
$1.14
$7.20

Aldeyra Therapeutics Inc Stock (ALDX) Company Profile

Name
Firmenname
Aldeyra Therapeutics Inc
Name
Telefon
781-761-4904
Name
Adresse
131 HARTWELL AVENUE, LEXINGTON, MA
Name
Mitarbeiter
8
Name
Twitter
@aldeyraaldx
Name
Nächster Verdiensttermin
2024-11-18
Name
Neueste SEC-Einreichungen
Name
ALDX's Discussions on Twitter

Vergleichen Sie ALDX mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Biotechnology icon
ALDX
Aldeyra Therapeutics Inc
3.515 160.82M 0 -44.80M -30.67M -0.75
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
446.33 115.95B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
520.07 56.52B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
322.00 39.44B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
561.00 35.14B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
266.92 28.51B 3.81B -644.79M -669.77M -6.24

Aldeyra Therapeutics Inc Stock (ALDX) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2024-04-03 Hochstufung Oppenheimer Perform → Outperform
2024-04-02 Fortgesetzt H.C. Wainwright Buy
2022-04-27 Fortgesetzt H.C. Wainwright Buy
2021-02-08 Eingeleitet H.C. Wainwright Buy
2020-12-16 Eingeleitet Berenberg Buy
2020-10-30 Eingeleitet Jefferies Buy
2020-10-16 Eingeleitet BTIG Research Buy
2020-09-22 Eingeleitet Alliance Global Partners Buy
2020-05-12 Eingeleitet Oppenheimer Outperform
2018-12-04 Eingeleitet Citigroup Buy
2018-09-26 Bestätigt Cantor Fitzgerald Overweight
2018-09-13 Eingeleitet Janney Buy
2018-01-26 Eingeleitet Seaport Global Securities Buy
2016-09-26 Eingeleitet H.C. Wainwright Buy
2016-07-01 Eingeleitet Stifel Buy
2015-07-01 Eingeleitet Canaccord Genuity Buy
2015-03-25 Eingeleitet Chardan Capital Markets Buy
2015-03-20 Bestätigt H.C. Wainwright Buy
2014-11-18 Eingeleitet H.C. Wainwright Buy
2014-06-19 Eingeleitet Aegis Capital Buy
Alle ansehen

Aldeyra Therapeutics Inc Aktie (ALDX) Neueste Nachrichten

pulisher
Jun 17, 2025

Aldeyra Therapeutics Resubmits Reproxalap NDA in Dry Eye Disease - HCPLive

Jun 17, 2025
pulisher
Jun 17, 2025

Aldeyra resubmits NDA for dry eye disease drug after trial success - Investing.com

Jun 17, 2025
pulisher
Jun 17, 2025

Aldeyra resubmits NDA for dry eye disease drug after trial success By Investing.com - Investing.com South Africa

Jun 17, 2025
pulisher
Jun 17, 2025

Aldeyra Therapeutics (ALDX) Resubmits FDA Application for Dry Ey - GuruFocus

Jun 17, 2025
pulisher
Jun 17, 2025

Aldeyra resubmits Reproxalap's marketing application to FDA - Seeking Alpha

Jun 17, 2025
pulisher
Jun 17, 2025

Aldeyra Therapeutics Resubmits New Drug Application For Dry Eye Drug; Shares Up Pre-Bell - MarketScreener

Jun 17, 2025
pulisher
Jun 17, 2025

Aldeyra Therapeutics Resubmits Reproxalap New Drug Application f - GuruFocus

Jun 17, 2025
pulisher
Jun 17, 2025

Aldeyra (ALDX) Resubmits Drug Application for Dry Eye Treatment to FDA | ALDX Stock News - GuruFocus

Jun 17, 2025
pulisher
Jun 17, 2025

Aldeyra Resubmits Reproxalap NDA to FDA - TipRanks

Jun 17, 2025
pulisher
Jun 17, 2025

Aldeyra's Dry Eye Drug Hits Major Trial Goal (P=0.002), FDA Application Resubmitted After Previous Rejection - Stock Titan

Jun 17, 2025
pulisher
Jun 11, 2025

Aldeyra Therapeutics Holds Annual Meeting with Key Votes - TipRanks

Jun 11, 2025
pulisher
Jun 10, 2025

Trend Tracker for (ALDX) - news.stocktradersdaily.com

Jun 10, 2025
pulisher
Jun 08, 2025

Two Sigma Investments LP Sells 15,349 Shares of Aldeyra Therapeutics, Inc (NASDAQ:ALDX) - Defense World

Jun 08, 2025
pulisher
Jun 07, 2025

161,926 Shares in Aldeyra Therapeutics, Inc (NASDAQ:ALDX) Purchased by Millennium Management LLC - Defense World

Jun 07, 2025
pulisher
Jun 07, 2025

SHAREHOLDER ALERT: Potential Recovery for Aldeyra Therapeutics, Inc. (ALDX) Investors Affected by Stock DropLevi & Korsinsky Pursuing Class Action Lawsuit - ACCESS Newswire

Jun 07, 2025
pulisher
Jun 06, 2025

Mackenzie Financial Corp Purchases 36,160 Shares of Aldeyra Therapeutics, Inc (NASDAQ:ALDX) - Defense World

Jun 06, 2025
pulisher
Jun 06, 2025

BNP Paribas Financial Markets Trims Stake in Aldeyra Therapeutics, Inc (NASDAQ:ALDX) - Defense World

Jun 06, 2025
pulisher
Jun 05, 2025

Bank of America Corp DE Reduces Stock Position in Aldeyra Therapeutics, Inc (NASDAQ:ALDX) - Defense World

Jun 05, 2025
pulisher
Jun 04, 2025

ProShare Advisors LLC Acquires Shares of 14,031 Aldeyra Therapeutics, Inc (NASDAQ:ALDX) - Defense World

Jun 04, 2025
pulisher
Jun 04, 2025

Two Sigma Advisers LP Sells 84,000 Shares of Aldeyra Therapeutics, Inc (NASDAQ:ALDX) - Defense World

Jun 04, 2025
pulisher
May 29, 2025

Trading (ALDX) With Integrated Risk Controls - news.stocktradersdaily.com

May 29, 2025
pulisher
May 29, 2025

Aldeyra Therapeutics to Participate in the 2025 Jefferies Global Healthcare Conference | ALDX Stock News - GuruFocus

May 29, 2025
pulisher
May 29, 2025

Aldeyra Therapeutics to Participate in the 2025 Jefferies Global Healthcare Conference - Business Wire

May 29, 2025
pulisher
May 26, 2025

Northern Trust Corp Purchases 16,894 Shares of Aldeyra Therapeutics, Inc (NASDAQ:ALDX) - Defense World

May 26, 2025
pulisher
May 25, 2025

Aldeyra Therapeutics, Inc (NASDAQ:ALDX) Shares Acquired by Deutsche Bank AG - Defense World

May 25, 2025
pulisher
May 24, 2025

D. E. Shaw & Co. Inc. Sells 146,198 Shares of Aldeyra Therapeutics, Inc (NASDAQ:ALDX) - Defense World

May 24, 2025
pulisher
May 23, 2025

Q3 Earnings Forecast for ALDX Issued By Leerink Partnrs - Defense World

May 23, 2025
pulisher
May 22, 2025

Aldeyra Therapeutics, Inc. (NASDAQ:ALDX): When Will It Breakeven? - Yahoo Finance

May 22, 2025
pulisher
May 22, 2025

HC Wainwright Has Strong Forecast for ALDX FY2029 Earnings - Defense World

May 22, 2025
pulisher
May 22, 2025

Q2 EPS Estimate for Aldeyra Therapeutics Lifted by Analyst - Defense World

May 22, 2025
pulisher
May 21, 2025

Aldeyra Therapeutics (NASDAQ:ALDX) Raised to “Sell” at StockNews.com - Defense World

May 21, 2025
pulisher
May 20, 2025

Balyasny Asset Management L.P. Acquires New Stake in Aldeyra Therapeutics, Inc (NASDAQ:ALDX) - Defense World

May 20, 2025
pulisher
May 20, 2025

Aldeyra Therapeutics (NASDAQ:ALDX) Given “Buy” Rating at HC Wainwright - Defense World

May 20, 2025
pulisher
May 19, 2025

ALDX: HC Wainwright & Co. Reiterates Buy Rating with $10 Target | ALDX Stock News - GuruFocus

May 19, 2025
pulisher
May 18, 2025

(ALDX) Trading Report - news.stocktradersdaily.com

May 18, 2025
pulisher
May 18, 2025

Pomerantz Law Firm Investigates Claims On Behalf of Investors of Aldeyra Therapeutics, Inc.ALDX - FinancialContent

May 18, 2025
pulisher
May 18, 2025

Aldeyra Therapeutics, Inc (NASDAQ:ALDX) Stock Holdings Lessened by Price T Rowe Associates Inc. MD - Defense World

May 18, 2025
pulisher
May 14, 2025

Bragar Eagel & Squire, P.C. Is Investigating Organon, Aldeyra, Landstar, and ICU Medical ... - Eagle-Tribune

May 14, 2025
pulisher
May 14, 2025

Bragar Eagel & Squire, P.C. Is Investigating Organon, - GlobeNewswire

May 14, 2025
pulisher
May 14, 2025

Aldeyra Therapeutics, Inc. SEC 10-Q Report - TradingView

May 14, 2025
pulisher
May 13, 2025

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Aldeyra - Bluefield Daily Telegraph

May 13, 2025
pulisher
May 13, 2025

Hsbc Holdings PLC Acquires Shares of 10,457 Aldeyra Therapeutics, Inc (NASDAQ:ALDX) - Defense World

May 13, 2025
pulisher
May 12, 2025

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Aldeyra Therapeutics, Inc.ALDX - PR Newswire

May 12, 2025
pulisher
May 11, 2025

SHAREHOLDER ALERT: Potential Recovery for Aldeyra Therapeutics, Inc. (ALDX) Investors Affected by Stock Drop – Levi & Korsinsky Pursuing Class Action Lawsuit - ACCESS Newswire

May 11, 2025
pulisher
May 11, 2025

Barclays PLC Has $376,000 Stake in Aldeyra Therapeutics, Inc (NASDAQ:ALDX) - Defense World

May 11, 2025
pulisher
May 08, 2025

(ALDX) Trading Advice - news.stocktradersdaily.com

May 08, 2025
pulisher
May 08, 2025

Bragar Eagel & Squire, P.C. Is Investigating RobinHood, - GlobeNewswire

May 08, 2025
pulisher
May 07, 2025

Bragar Eagel & Squire, P.C. Is Investigating RobinHood, Aldeyra, Landstar, and ICU Medical ... - Eagle-Tribune

May 07, 2025
pulisher
May 07, 2025

Bragar Eagel & Squire, P.C. Is Investigating RobinHood, Aldeyra, Landstar, and ICU Medical and Encourages Investors to Contact the Firm - TradingView

May 07, 2025
pulisher
May 07, 2025

Aldeyra Therapeutics Drops To US$2.10, Yet Insiders May Have Sold Too Early - simplywall.st

May 07, 2025
pulisher
May 07, 2025

ALDX SECURITIES UPDATE: Aldeyra Therapeutics Investors with - GlobeNewswire

May 07, 2025

Finanzdaten der Aldeyra Therapeutics Inc-Aktie (ALDX)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading

Aldeyra Therapeutics Inc-Aktie (ALDX) Insiderhandel

Insiderhandel Beziehung Datum Transaktion Kosten #Aktien Wert ($) #Aktien Gesamt
Machatha Stephen
Chief Development Officer
Aug 12 '24
Sale
4.74
16,041
75,975
236,771
Greenberg Bruce
See Remarks
Aug 12 '24
Sale
4.74
10,834
51,313
126,382
$20.54
price down icon 0.92%
$35.85
price down icon 0.75%
$20.87
price down icon 0.26%
$104.58
price down icon 1.02%
$102.67
price down icon 2.16%
biotechnology ONC
$266.39
price up icon 0.01%
Kapitalisierung:     |  Volumen (24h):